Microdosing Semaglutide Tablets

Semaglutide is a GLP-1 receptor agonist that mimics the action of the natural GLP-1 hormone involved in appetite regulation and glucose signaling. By activating GLP-1 receptors, semaglutide may help you feel full sooner, stay satisfied longer, and reduce hunger cues—supporting lower overall calorie intake over time.

Microdosing refers to a lower-starting-dose strategy tailored by a clinician and adjusted gradually to balance progress with tolerability.

Take the tablets exactly as prescribed, typically on a consistent daily schedule. Your clinician will determine your starting dose and may adjust it gradually based on your goals, response, and tolerability.

Helpful routine tips:

• Take your dose at the same time each day to build consistency
• Follow any instructions about food (with or without meals) provided by your clinician
• If you miss a dose, follow your clinician’s guidance—do not double up unless instructed
• Keep regular follow-ups so your clinician can monitor progress and side effects

Semaglutide may cause side effects. The most commonly reported include:

• Nausea
• Diarrhea
• Constipation
• Vomiting
• Stomach discomfort
• Decreased appetite

Side effects are often most noticeable when starting treatment or adjusting dose. A gradual, clinician-guided approach may help improve tolerability for some people. Seek medical attention for severe or persistent symptoms, signs of an allergic reaction, or severe abdominal pain.